Home

Fami tot posibilul cilia silabă ipf 2015 summary table 1 În orice moment Drept Ramolit

overview of major clinical trials undertaken in ipF. | Download Table
overview of major clinical trials undertaken in ipF. | Download Table

Epidemiology, healthcare utilization, and related costs among patients with  IPF: results from a German claims database analysis | Respiratory Research  | Full Text
Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis | Respiratory Research | Full Text

PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline :  Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of  the 2011 Clinical Practice Guideline | Semantic Scholar
PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar

Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary  Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN

Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and  Recent Developments in the Treatment Landscape
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape

Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary  Fibrosis | Semantic Scholar
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of  Idiopathic Pulmonary Fibrosis: Executive Summary
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: Executive Summary

IJMS | Free Full-Text | Identification of Impacted Pathways and  Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in  Transgenic Mice Expressing Human IGFBP5 | HTML
IJMS | Free Full-Text | Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5 | HTML

Patient journey and treatment patterns in adults with IPF based on health  care data in Sweden from 2001 to 2015 - Respiratory Medicine
Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine

Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and  Recent Developments in the Treatment Landscape
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape

Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a  Chinese cohort of a long-term follow-up study | Chinese Medical Journal
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal

Key recommendations on pharmacological treatment of IPF according to... |  Download Table
Key recommendations on pharmacological treatment of IPF according to... | Download Table

Implementation of guideline recommendations and outcomes in patients with  idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory  Medicine
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine

Validation of a 52-gene risk profile for outcome prediction in patients  with idiopathic pulmonary fibrosis: an international, multicentre, cohort  study - The Lancet Respiratory Medicine
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine

Therapeutic decisions in a cohort of patients with idiopathic pulmonary  fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska,  Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk,  Hanna Jagielska-Len, Ewa Jassem,
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,

Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer  patients | Scientific Reports
Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients | Scientific Reports

The genetic basis of idiopathic pulmonary fibrosis | European Respiratory  Society
The genetic basis of idiopathic pulmonary fibrosis | European Respiratory Society

Paired analysis of tumor mutation burden for lung adenocarcinoma and  associated idiopathic pulmonary fibrosis | Scientific Reports
Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis | Scientific Reports

National data on prevalence of idiopathic pulmonary fibrosis and  antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory  Research
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research

Comparison of recommendations in the 2015 and 2011 idiopathic pulmonary...  | Download Table
Comparison of recommendations in the 2015 and 2011 idiopathic pulmonary... | Download Table

Table 1 from Idiopathic Pulmonary Fibrosis. | Semantic Scholar
Table 1 from Idiopathic Pulmonary Fibrosis. | Semantic Scholar

Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival  analysis using visual and computer-based computed tomography assessment -  eClinicalMedicine
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine

Drug Interactions With Interstitial Lung Disease Pharmacotherapy
Drug Interactions With Interstitial Lung Disease Pharmacotherapy

Forced vital capacity trajectories in patients with idiopathic pulmonary  fibrosis: a secondary analysis of a multicentre, prospective, observational  cohort - The Lancet Digital Health
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health